Position in ABSI
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,546,046
+$3,922,500 QoQ
Shares Held
478,520
-11.6% QoQ
Ownership
0.279%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#42
of 195 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $72,560,422 across 12 Biotechnology names. ABSI ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
381,991 | $20,833,789 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
455,954 | $15,648,341 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
777,948 | $13,162,880 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
2,604,317 | $9,557,843 | |
| 5 | ABSI |
Absci Corp
This page
|
478,520 | $5,546,046 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
89,885 | $2,180,610 | |
| 7 | ATAI |
AtaiBeckley Inc.
|
252,913 | $1,332,851 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
15,819 | $1,254,288 |
All Filings in ABSI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,546,046 | 478,520 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,623,546 | 541,182 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,641,647 | 470,386 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $936,502 | 308,060 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $406,825 | 158,298 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $221,894 | 88,404 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $80,520 | 30,733 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $53,392 | 13,977 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||